Multiple System Atrophy
Showing 26 - 50 of >10,000
Parkinson Disease, MSA - Multiple System Atrophy, Chronic Pain Trial in Oxford (Deep brain stimulation)
Completed
- Parkinson Disease
- +3 more
- Deep brain stimulation
-
Oxford, Oxfordshire, United KingdomJohn Radcliffe Hospital
Nov 1, 2022
Multiple System Atrophy Trial in Shanghai (Spinal cord stimulation)
Recruiting
- Multiple System Atrophy
- Spinal cord stimulation
-
Shanghai, Shanghai, ChinaDepartment of Neurology and Institute of Neurology, Ruijin Hospi
Dec 28, 2021
Multiple System Atrophy Trial in Japan, United States (Lu AF82422, Placebo)
Active, not recruiting
- Multiple System Atrophy
- Lu AF82422
- Placebo
-
Fountain Valley, California
- +18 more
Dec 5, 2022
Observational Study in Multiple System Atrophy
Recruiting
- Multiple System Atrophy
- plasma NfL and brain MRI (vMRI, DTI, and ASL [if feasible]) only for the EU cohort
-
Beijing, China
- +8 more
Jul 13, 2022
Multiple System Atrophy Trial in Rochester (Autologous Mesenchymal Stem Cells, Placebo)
Recruiting
- Multiple System Atrophy
- Autologous Mesenchymal Stem Cells
- Placebo
-
Rochester, MinnesotaMayo Clinic
Jan 18, 2022
Synaptic Loss in Multiple System Atrophy
Recruiting
- Multiple System Atrophy
- Study procedures
-
Exeter, United KingdomUniversity of Exeter
Nov 9, 2021
Facilitating Diagnostics and Prognostics of Parkinsonian
Recruiting
- Parkinson Disease
- +2 more
-
Dallas, TexasUT Southwestern Medical Center
Sep 26, 2022
Longitudinal Tracking of Patients Diagnosed With
Not yet recruiting
- Neurodegenerative Diseases
- +4 more
- (no location specified)
Aug 16, 2022
Parkinson's Disease and Parkinsonism, Progressive Supranuclear Palsy, Multiple System Atrophy Trial in Dublin (Free-viewing eye
Recruiting
- Parkinson's Disease and Parkinsonism
- +3 more
- Free-viewing eye tracking
-
Dublin, Leinster, IrelandDublin Neurological Institute at the Mater Misericordiae Univers
Nov 27, 2022
Ataxia, Spinocerebellar Ataxias, Multiple System Atrophy Trial in Brescia (Transcranial stimulation over the cerebellar
Completed
- Ataxia
- +4 more
- Transcranial stimulation over the cerebellar hemispheres
-
Brescia, BS, ItalyASST Spedali Civili di Brescia
Dec 23, 2022
Pain and Autonomic Symptoms in Parkinson's Disease and Atypical
Recruiting
- Parkinson Disease
- Multiple System Atrophy
- Rehabilitation
- Administration of Clinical scales
-
Telese Terme, Benevento, Italy
- +8 more
Feb 17, 2023
Parkinson's Disease and Other Synucleinopathies (EASE-PD)
Active, not recruiting
- Parkinson's Disease
- Multiple System Atrophy
-
Wuhan, Hubei, China
- +3 more
Nov 28, 2022
Multiple System Atrophy Trial in New York (Sirolimus 2 MG, Placebo)
Terminated
- Multiple System Atrophy
- Sirolimus 2 MG
- Placebo
-
New York, New YorkNew York University School of Medicine
Nov 8, 2021
Phase 1 Clinical Trial of CS10BR05(CS10BR05-MSA101)
Active, not recruiting
- Multiple System Atrophy
-
Seoul, Korea, Republic ofYonsei University College of Medicine
Mar 8, 2022
Parkinson Disease, Multiple System Atrophy, Non-celiac Gluten Sensitivity Trial in Prague (gluten-free diet)
Recruiting
- Parkinson Disease
- +2 more
- gluten-free diet
-
Prague, CzechiaGUHPrague
Mar 30, 2022
Parkinson Disease Dementia, Parkinson Disease, Parkinson's Disease and Parkinsonism Trial in Rochester (Parkinson Disease
Recruiting
- Parkinson Disease Dementia
- +8 more
- Parkinson Disease Standard Care
- Online Community-Supported Palliative Care
-
Rochester, New YorkUniversity of Rochester Medical Center for Health + Technology
Jan 10, 2023
Alpha-synuclein Aggregates Across Biofluid Reservoirs in
Active, not recruiting
- Parkinson Disease
- +3 more
- Biomarker assay
-
Stony Brook, New YorkStony Brook University Medical Center
May 3, 2022
MSA - Multiple System Atrophy Trial in Oxford (Deep brain stimulation)
Recruiting
- MSA - Multiple System Atrophy
- Deep brain stimulation
-
Oxford, Oxfordshire, United KingdomJohn Radcliffe Hospital
Jan 5, 2022
Neurogenic Orthostatic Hypotension Trial in New York, Nashville (Atomoxetine, Placebo)
Completed
- Multiple System Atrophy (MSA)
- Atomexetine
- Placebo
-
New York, New YorkNew York University School of Medicine
Jan 4, 2022
Atypical Parkinsonism, MSA - Multiple System Atrophy, PSP Trial in Italy (Telemonitoring, Standard-of-care)
Not yet recruiting
- Atypical Parkinsonism
- +4 more
- Telemonitoring
- Standard-of-care
-
Messina, Italy
- +3 more
Mar 18, 2023
Biomarkers in Parkinsonian Syndromes
Recruiting
- Parkinsonian Syndromes
- +3 more
- CSF, blood and urine sampling
- clinical measures of disease severity and progression
-
Limoges, France
- +2 more
Mar 30, 2022
Autonomic Failure, Pure Autonomic Failure, Parkinson Disease Trial in Nashville ([18F]FDOPA, Carbidopa 200mg oral dose,
Recruiting
- Autonomic Failure
- +4 more
- [18F]FDOPA
- +2 more
-
Nashville, TennesseeVanderbilt University Medical Center
Apr 14, 2022
Neurogenic Orthostatic Hypotension, Multiple System Atrophy (MSA) With Orthostatic Hypotension, Pure Autonomic Failure Trial in
Completed
- Neurogenic Orthostatic Hypotension
- +7 more
- TD-9855
- Placebo
-
Long Beach, California
- +5 more
Aug 30, 2022
Multiple System Atrophy Trial in Bordeaux (Multimodal intervention)
Recruiting
- Multiple System Atrophy
- Multimodal intervention
-
Bordeaux, FranceCHU Bordeaux
Aug 4, 2021
Parkinson Disease, Parkinson's Disease and Parkinsonism, Progressive Supranuclear Palsy Trial in Phoenix (Complex eye movement
Completed
- Parkinson Disease
- +9 more
- Complex eye movement exam
-
Phoenix, ArizonaDignity Health / St. Joseph's Hospital and Medical Center
May 3, 2022